Granulat mit Kontrollierter Freisetzung
EP4736847
6. Mai 2026
Anmelder: Farmolab S.L., Umbrella Business Group, S.L. 🇪🇸
Details
- Veröffentlichungs-Nr.
- EP4736847
- Anmeldetag
- 30. Oktober 2024
- Veröffentlichung
- 6. Mai 2026
- Rechtsraum
- EP
Abstract
The invention relates to a controlled release granulate comprising: a microcrystalline cellulose core; a first coating comprising vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B9, vitamin B12, a source of Zn, R-lipoic acid, or an acceptable salt or racemate, L-carnosine or an acceptable salt, olive extract as hydroxytyrosol source, and at least one antioxidant, and a second coating deposited upon the first coating comprising a modified cellulose and/or an hydroalcoholic polymer. Also relates to a process to obtain such controlled release granulate and its use in a method to treat or prevent pain.
Anmelder
- Firmen
- Farmolab S.L.
Umbrella Business Group, S.L. - Land
- 🇪🇸 Spanien